
Design software maker Figma's shares surge 158% in blowout market debut
Figma's shares surged nearly 158 per cent in their market debut on Thursday valuing the design software maker at about US$50 billion, setting the stage for a flurry of high-growth tech listings and strengthening a rebound in the IPO market.
The U.S. initial public offerings market has bounced back after tariff-driven volatility briefly paused listings in April, putting 2025 on track to end a nearly three-year dry spell.
Figma's valuation at debut far exceeds the $20 billion price tag from a now-abandoned buyout deal with industry giant Adobe in December 2023.
'Fast-growing software IPOs have been extremely rare during the past three years, so deals like this tend to get a lot of attention,' said Matt Kennedy, senior strategist at Renaissance Capital, a provider of IPO-focused research and ETFs.
'Because of this three-year bottleneck, tech IPO investors have been starved for new deals.'
The stock opened for trading at $85 apiece on the New York Stock Exchange, compared with the initial public offering price of $33.
Recent tech IPOs have drawn strong investor interest and delivered solid post-listing gains, fueling optimism around new offerings from high-growth and AI-focused firms.
'From a private markets perspective, Figma's IPO is a bellwether event for the tech sector,' said Derek Hernandez, senior analyst, emerging technology at PitchBook.
Figma makes collaborative design software used to build websites, apps and digital products, and customers include streaming giant Netflix, travel firm Airbnb and language learning app Duolingo.
Its prominent backers include Silicon Valley venture capital giants Kleiner Perkins and Sequoia.
'If you look at Figma's positioning around AI, and the ability to deliver massively improved experiences to its customers with AI, that was not obvious back in 2022,' said Andrew Reed, a partner at Sequoia Capital and a board member of Figma.
Sequoia Capital first invested in Figma at $1.10 a share during the company's Series C round. With Figma pricing its IPO at $33 a share, Sequoia stands to make a significant return on its roughly $150 million investment, according to a source familiar with the matter.
Meanwhile, the broader markets touched new record highs on Thursday as Microsoft's blockbuster earnings fueled investor confidence in Big Tech's hefty investments in artificial intelligence. .N
AI Race
Design software firms are racing to integrate generative-AI tools that automate tasks such as image creation, layout suggestions and code generation, as companies jostle to win enterprise clients and creative teams.
Figma, in its IPO filing, flagged intense competition, particularly from rapid AI adoption, as a potential headwind, warning it could cede market share.
'We've embedded different flavors of AI - both to lower the floor (and) allow more people to participate in the design process - while also raising the ceiling for individuals (and) for companies to be able to have even more high craft in what they're creating,' said Chief Financial Officer Praveer Melwani.
The effort has accelerated since Adobe, Microsoft and others began rolling out AI features aimed at speeding up workflows and cutting costs.
'Software companies with a strong AI element to them seem to be assets that investors want to buy,' said Will Braeutigam, U.S. capital markets transactions leader at Deloitte.
Figma, for its part, has rolled out several products built around AI as it looks to stay competitive and meet growing demand for automation in design workflows.
'If this company didn't have an AI strategy, it would not be seeing this level of demand,' Renaissance Capital's Kennedy said.
Morgan Stanley, Goldman Sachs, Allen & Co and J.P. Morgan are the lead underwriters of the IPO.
(Reporting by Manya Saini and Niket Nishant in Bengaluru and Echo Wang in New York; Additional reporting by Pritam Biswas; Editing by Sriraj Kalluvila and Tasim Zahid)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
2 minutes ago
- Globe and Mail
Paramount Global Reports Strong Q2 2025 Earnings
Paramount Global ( (PARA)) has released its Q2 earnings. Here is a breakdown of the information Paramount Global presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Paramount Global is a leading global media and entertainment company known for its extensive portfolio of iconic brands, including CBS, Paramount Pictures, and Paramount+, offering a wide range of content and streaming services. In its latest earnings report for Q2 2025, Paramount Global highlighted its continued transformation into a streaming-first company, with direct-to-consumer (DTC) revenue growing by 15% year-over-year, driven by the strong performance of Paramount+. The company's total revenue increased by 1% compared to the previous year, with notable growth in affiliate and subscription revenue. Paramount+ saw a 23% increase in total revenue and a 24% rise in subscription revenue, reflecting improved watch time and reduced churn. Despite a 6% decline in TV media revenue, the company achieved significant milestones in its content offerings, with CBS maintaining its position as the most-watched broadcast network in primetime for the 17th consecutive season. Paramount Pictures also reported a successful quarter, with the global premiere of 'Mission: Impossible – The Final Reckoning' setting a franchise record for the biggest global opening. Looking ahead, Paramount Global's management remains optimistic about the company's growth prospects, emphasizing the strength of its content strategy and the ongoing expansion of its streaming services.


Globe and Mail
an hour ago
- Globe and Mail
Comcast Reports Strong Q2 2025 Earnings Growth
Comcast Corp ( (CMCSA)) has released its Q2 earnings. Here is a breakdown of the information Comcast Corp presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Comcast Corporation is a global media and technology company that provides broadband, wireless, and video services through brands like Xfinity and Sky, and produces and distributes content via NBC, Universal, and Peacock, among others. In its second-quarter earnings report for 2025, Comcast Corporation announced a 2.1% increase in revenue to $30.3 billion and a significant rise in net income attributable to Comcast to $11.1 billion, largely due to a $9.4 billion gain from the sale of its interest in Hulu. The company also reported a 3.3% increase in adjusted earnings per share to $1.25 and generated $4.5 billion in free cash flow. Comcast's wireless business achieved record growth, adding 378,000 lines, and its theme parks segment saw a revenue increase of 18.9%, driven by the opening of Epic Universe. The company's media segment also performed well, with Peacock revenue up 18%. Despite a decrease in adjusted net income by 1.7%, Comcast returned $2.9 billion to shareholders through dividends and share repurchases. Looking ahead, Comcast remains confident in its strategic focus and capital allocation, positioning itself well for future growth with plans to expand its content offerings, including NBA coverage on Peacock.


Globe and Mail
an hour ago
- Globe and Mail
AbbVie Reports Strong Q2 2025 Financial Results
Abbvie ( (ABBV)) has released its Q2 earnings. Here is a breakdown of the information Abbvie presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. AbbVie Inc. is a global biopharmaceutical company that focuses on discovering and delivering innovative medicines in key therapeutic areas such as immunology, neuroscience, oncology, and eye care, alongside its Allergan Aesthetics portfolio. In the second quarter of 2025, AbbVie reported a strong financial performance with an increase in net revenues and adjusted earnings per share, highlighting the company's diversified growth platform and strategic investments in innovation. Key financial metrics from the quarter include a 6.6% increase in net revenues to $15.423 billion, driven by significant growth in the immunology and neuroscience portfolios. Skyrizi and Rinvoq showed substantial revenue increases of 62.2% and 41.8%, respectively, while the neuroscience portfolio grew by 24.2%. However, the aesthetics portfolio saw a decline of 8.1% in revenues. AbbVie also announced several strategic advancements, including FDA approvals for new treatments and positive clinical trial results, which bolster its pipeline and future growth prospects. The company has raised its full-year 2025 adjusted diluted EPS guidance, reflecting confidence in continued momentum. Looking ahead, AbbVie remains optimistic about its growth trajectory, supported by its robust pipeline and strategic initiatives, as it continues to focus on delivering innovative solutions to address significant health challenges.